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Abstract 13 
Infected host tissues have complex anatomy, diverse cell types, and dynamic inflammation. 14 
Traditional infection biology approaches largely ignore this complex host environment and its impact 15 
on pathogens, but recent single-cell technologies unravel extensively heterogeneous host-pathogen 16 
interactions in vivo. Salmonella are major model pathogens in this field due to the availability of 17 
excellent mouse disease models and facile molecular biology. The results show how Salmonella 18 
stochastically vary their virulence, exploit differential nutrient availability, experience and respond to 19 
widely varying stresses, and have disparate fates ranging from vigorous proliferation to eradication 20 
within the same host tissue. Specific Salmonella subsets drive disease progression, while others 21 
persist during antimicrobial chemotherapy. Further elucidation of the underlying mechanisms could 22 
provide a basis for improved infection control.  23 
Introduction 24 
During infection, pathogens often colonize host tissues with complex anatomy, diverse cell types and 25 
microenvironments with different physico-chemical parameters and divergent molecular composition. 26 
Pathogens can adopt a large variety of physiological states and stress defense programs in these highly 27 
heterogeneous environments. This externally triggered pathogen heterogeneity will add to the 28 
inevitable internal variation due to stochastic molecular fluctuations in the pathogen. The resulting 29 
rich diversity of pathogen behavior has been largely ignored until recently, in part because available 30 
methodology provided only bulk average readouts that could not resolve variation between pathogen 31 
subpopulations. However, in the past few years, single-cell approaches have been starting to reveal 32 
fascinating diversity of host-pathogen interactions in infected tissues [1-3].  33 
 These data provide the basis for a paradigm shift to single-cell pathogen infection biology for 34 
better understanding fundamental mechanisms that determine course of disease and treatment 35 
outcome. Individual pathogen-host encounters involve divergent cellular and molecular mechanisms 36 
that lead to disparate outcomes within the same tissue that range from local pathogen eradication to 37 
vigorous proliferation in adjacent infection foci [1-3]. Disease progression hence does not reflect a 38 
general inability of host immunity to control the pathogen. Instead, the host seems often have 39 
powerful effector mechanisms that efficiently kill pathogen, but fails to employ these mechanisms 40 
against all dispersed pathogens, resulting in local lack of control. Likewise, antimicrobial 41 
chemotherapy might rapidly kill a large fraction of pathogens, but some pathogen subsets might hide 42 
in microenvironments that are poorly reachable for drugs [4], or adopt physiological states that make 43 
them tolerant against antibiotics [5-7]. Such surviving pathogens will require extended treatments to 44 
minimize the risk of relapses. We need to understand better the pathogen subsets that escape efficient 45 
immune control and antimicrobial chemotherapy to enable more efficient infection control strategies.  46 
 Salmonella infections in mice provide unique opportunities for developing concepts and 47 
approaches that might be broadly applicable to other infection models. In particular, well-48 
characterized mouse infection models, facile Salmonella genetics and suitability for numerous 49 
experimental approaches, as well as extensive literature make Salmonella one of the best-studied 50 
pathogens. The mouse is a natural host of various Salmonella enterica serovars. Low doses of 51 
Salmonella enterica serovar Typhimurium can cause systemic infections in genetically susceptible 52 
mice that reproduce some aspects of human typhoid fever (which is caused by human-adapted 53 
serovars Typhi and Paratyphi) [8], and the recent re-establishment of experimental human models of 54 
typhoid/paratyphoid fever [9,10] offers exciting possibilities to compare at murine and human 55 
infections under well-controlled infection conditions. Infection of genetically resistant mice can lead 56 
to chronic infections with low but stable Salmonella tissue loads in spite of a strong immune response 57 
[11]. Mice do not normally develop diarrhea, but disruption of the normal gut microbiota by a single 58 
dose of streptomycin overcomes Salmonella colonization resistance, and provides a versatile and 59 
widely used enteritis model [12].  60 
Suitable animal and cell-culture infection models, together with facile molecular biology have 61 
made Salmonella a prime pathogen for developing numerous innovative approaches. This includes in 62 
vivo expression technology (IVET) [13], signature-tagged mutagenesis (STM) [14], differential 63 
fluorescence induction (DFI) [15], ex vivo proteomics [16], population dynamics with wild-type 64 
isogenic tagged strains (WITS) [17], fluorescence dilution (FD) [18], TIMER growth rate reporter 65 
[19], ex vivo isolation of pathogen subpopulations [20], dual RNA-seq [21], single-cell RNA-seq of 66 
infected cells [22,23], etc. As part of this general history of Salmonella as a suitable model pathogen 67 
for developing novel methodology, single-cell techniques such as confocal microscopy, flow 68 
cytometry coupled with informative fluorescent reporter constructs, and single cell RNAseq are 69 
starting to yield unique insights into Salmonella in vivo heterogeneity in expression, growth rate, 70 
stress exposure, antimicrobial tolerance, and single-cell fates. Some of these methods have been 71 
recently covered in other reviews [2,24-26]. Here, we will focus on the results that have been obtained 72 
and open questions in this new field. 73 
 74 
Salmonella growth rate 75 
Early studies revealed extensive differences in Salmonella growth rate, gene expression, and 76 
proteome in gut lumen vs. mucosal tissues and spleen of infected mice [12,16,27-29]. A major switch 77 
occurs in Salmonella that invade gut epithelial cells and turn on expression of a type three secretion 78 
system encoded on Salmonella pathogenicity island 2 (SPI-2), which is associated with intracellular 79 
growth. A recent study showed that many Salmonella originating from the gut lumen and arriving at 80 
mesenteric lymph nodes are in an extended lag phase [30], perhaps while they re-program their 81 
gene expression as required for the new tissue microenvironment.  82 
Maybe more surprisingly, Salmonella shows also extensive heterogeneity even within a 83 
single host organ. In the enteritis model, Salmonella splits into two intestinal subpopulations with 84 
one rapidly proliferating subset with low virulence gene expression and another more slowly 85 
growing subset with high levels of the invasion-associated type three secretion system encoded on 86 
Salmonella pathogenicity island 1 (SPI-1) [31] (Fig. 1). This heterogeneity seems to reflect stochastic 87 
variations in hilD gene expression [32], but the underlying molecular mechanisms remain unclear. 88 
The SPI-1 ON subset invades the mucosa, causes inflammation, and is partially cleared by the host 89 
immune system. However, the gut inflammation that is triggered by this SPI-1 ON subset suppresses 90 
competing gut microbiota thus enabling the SPI-1 OFF subset to thrive. This is a striking example of 91 
“division of labor” or cooperative virulence among pathogen subpopulations. Another advantage of 92 
bistable expression of SPI-1 is the maintenance of a well-growing subset. This subset competes 93 
effectively against cheater mutants that completely switch off SPI-1, but exploit benefits generated 94 
by wild-type subsets with high SPI-1 activity [33]. 95 
 Salmonella also shows highly heterogeneous growth rates when they reside mostly 96 
intracellularly in systemic mouse tissues such mesenteric lymph nodes, spleen, and the gall bladder 97 
epithelium [18,19,34,35]. Early after oral infection and tissue invasion, a small Salmonella subset 98 
remains in an extended lag phase with no detectable cell division [18]. This extensive lag phase is 99 
triggered by induction of toxin proteins of toxin/anti-toxin modules such as an aminoacyl-tRNA 100 
acetylase TacT [36], possibly in response to low pH and poor nutrient availability in intracellular 101 
Salmonella-containing vacuoles [34]. However, as disease progresses such growth-arrested subsets 102 
become very rare [19,34] due to overgrowth by replicating Salmonella and perhaps some wake-up 103 
from lag phase and/or clearance by host immunity.  104 
Growth-arrested subsets in the mesenteric lymph nodes stay at more constant levels in the 105 
mouse enteritis model, in which endogenous gut microbiota are largely eradicated by prior 106 
streptomycin treatment [30]. Under these conditions, Salmonella maintain very high loads in the gut 107 
lumen with bistable SPI-1 expression (see above). Only the SPI-1 ON subset continuously travels to 108 
the mesenteric lymph nodes [37]. Many of the new arrivers remain apparently in extended lag 109 
phases, especially when the reside in classical dendritic cells (but not in interstitial dendritic cells) 110 
[30] (Fig. 1). 111 
In presence of a normal gut microbiota, Salmonella colonizes the gut lumen only transiently 112 
and Salmonella colonizes the Peyer's patches and disseminates to systemic tissues such as 113 
mesenteric lymph node, spleen, and liver. When disease signs become visible, practically all 114 
Salmonella cells in these various tissues grow, but their division rates are highly divergent [19]. A 115 
minor fast-growing subset drives bacterial tissue loads and disease progression, but much of its 116 
offspring slows down to mostly moderate growth rates, while only a minority maintains the high 117 
division rates. Subset isolation, proteomics, and metabolic network analysis of fast vs. slow growing 118 
subsets suggest that these growth rates reflect at least in part differential supply of nutrients such as 119 
nucleosides and amino acids. Surprisingly, diverse host cells such as red pulp resident macrophages 120 
and neutrophils support a similar range of intracellular Salmonella growth rates, and what 121 
determines differential nutrient supply is still unclear. Although we have yet no evidence for 122 
additional heterogeneity-promoting factors such as Salmonella internal stochastic variations, such 123 
contributions might play an important role (as they apparently do in the gut for virulence gene 124 
expression, see above).  125 
 126 
Salmonella tolerance to antimicrobial chemotherapy 127 
Heterogeneous in vivo growth rates can have a dramatic impact on antimicrobial chemotherapy. 128 
Non-growing Salmonella that reside in in mesenteric lymph nodes seem to be partially resilient 129 
against early high-dose treatment with fluoroquinolone antibiotics. However, if such “survivors” 130 
retain actual colony-forming capabilities (i.e., full viability) seems to depend on subtle experimental 131 
details [19,30,34,38]. It has also been proposed that Salmonella detected in mesenteric lymph nodes 132 
during therapy might actually represent Salmonella dynamically entering from unidentified intestinal 133 
sites during therapy, instead of locally persisting Salmonella [38]. As SPI-1 expression is required for 134 
tissue invasion and reaching the mesenteric lymph nodes, antibiotic treatment actually favors 135 
survival of the virulent subset in the apparently privileged mesenteric lymph nodes during 136 
antimicrobial therapy, providing a fascinating connection between cooperative virulence and 137 
antimicrobial tolerance [37]. Fluoroquinolones retain partial bactericidal activity against non-dividing 138 
bacteria in vitro, suggesting that additional in vivo factors might further enhance survival of this 139 
Salmonella subset. Such factors could include diminished bactericidal activity of fluoroquinolones at 140 
high concentrations and/or low oxygen tension [39]. 141 
During systemic infection, a non-proliferating Salmonella mutant is largely resilient against 142 
high-dose fluoroquinolone treatment [40], but it is unclear if this is relevant for normal infections. To 143 
assess this issue, we orally infected mice with wild-type Salmonella and started treatment after 144 
appearance of clinical disease signs (day 5 post oral infection) with only moderate doses [19]. Under 145 
these more clinically representative conditions, killing efficacy again strongly correlates with 146 
Salmonella growth rates. However, instead of non-growing Salmonella (which are rare under these 147 
conditions), abundant moderately growing Salmonella subsets with still substantial antimicrobial 148 
tolerance are mostly responsible for slow eradication during treatment. Together, these data show 149 
how Salmonella in vivo phenotypic heterogeneity can impair antimicrobial chemotherapy, even in 150 
absence of any inheritable resistance. This Salmonella in vivo tolerance could reflect internal 151 
stochastic fluctuations in Salmonella (as widely studied in vitro). On the other hand, host factors 152 
such as stresses in the Salmonella-containing vacuole that induce high persister frequencies [33], 153 
differential nutrient access leading to a wide range of growth rates and antimicrobial tolerance  [19] 154 
seem to have a major impact.  155 
 156 
Salmonella stress exposure and fates 157 
In addition to differential nutrient access, individual Salmonella cells also experience widely varying 158 
stress conditions as part of antimicrobial host attacks [20]. In particular, regional accumulation of 159 
inflammatory monocytes expressing high levels of inducible nitric oxide synthase (iNOS) exposes 160 
local Salmonella to nitric oxide (NO). Isolation and proteome analysis of the affected Salmonella 161 
subset (using a NO-inducible reporter) showed that they respond by specific upregulating of just 162 
three NO detoxification/repair proteins that effectively alleviate NO toxicity. As a result, iNOS has no 163 
impact on Salmonella fitness during the first week of acute infection. In parallel, Salmonella 164 
spreading to new host cells experience transient oxidative bursts that expose them to a variety of 165 
reactive oxygen species (ROS) [20]. The affected Salmonella subset upregulates specific 166 
detoxification enzymes such as catalase KatG and peroxidase AhpCF, in addition to a general high 167 
baseline level of other detoxification enzymes (superoxide dismutase SodCI, peroxidase TsaA). This 168 
Salmonella defense is effective against moderate oxidative bursts employed by red pulp resident 169 
macrophages, but insufficient to cope with the more powerful oxidative bursts in neutrophils and 170 
inflammatory monocytes [19]. These latter cell types use the abundant enzyme myeloperoxidase to 171 
convert superoxide and peroxide to highly reactive hypochlorite (bleach) at the Salmonella surface 172 
[41]. Hypochlorite immediately reacts with any biomolecule confining its damaging action to the 173 
Salmonella envelope and the immediate surroundings, thereby minimizing collateral host tissue 174 
damage. 175 
 These data suggest that some Salmonella can effectively cope with certain host stresses with 176 
little impact on their fitness. Indeed, slow- and fast-growing Salmonella experience similar NO and 177 
ROS stress based on their proteome profiles [19], suggesting that these stresses have limited impact 178 
on division rates. On the other hand, neutrophils and inflammatory monocytes kill a significant 179 
number of Salmonella cells using oxidative bursts.  180 
This highly divergent impact of stress on different Salmonella subsets that coexist in the 181 
same infected host tissue resolves apparently contradicting previous bulk average data on the 182 
impact of host ROS. The accumulation of neutrophils and monocytes around growing Salmonella 183 
infection foci and the resulting increasingly potent local control, could also explain the early finding 184 
that Salmonella tissue loads are mostly driven by spreading and formation of new infection foci, 185 
whereas old foci are less productive for Salmonella growth [42]. The host clearly has the capability to 186 
kill Salmonella effectively, and an eventually fatal disease outcome reflects the insufficient ability to 187 
employ these mechanisms rapidly enough against all emerging infection, rather than a general 188 
superiority of Salmonella virulence mechanisms and/or weak host immunity. This is a striking 189 
parallel to tuberculosis, where successful host control and vigorous Mycobacterium tuberculosis 190 
growth occur in close vicinity in the same infected host tissue [3].  191 
 192 
Salmonella heterogeneity as a tool for in-depth analysis of specific mechanisms 193 
The published data show a large complexity of concomitant individual host-pathogen encounters in 194 
vivo with diverse molecular mechanisms and disparate outcomes for dozens of distinct Salmonella 195 
subsets. Ongoing studies reveal even more Salmonella heterogeneity, and it will be challenging to 196 
understand and interpret all these overlapping complexities. On the other hand, the comparison of 197 
distinct Salmonella subsets actually simplifies the analysis of individual host conditions, as it enables 198 
to compare affected subsets directly to unaffected Salmonella subsets from the same tissue (which 199 
can serve as ideal “controls”). As an example, this approach revealed a highly focused Salmonella 200 
response to local host NO involving just three proteins, compared to much more complex in vitro 201 
responses that can be further convoluted by interference with the iron-dependent transcriptional 202 
regulator Fur [43].  203 
 204 
Conclusions 205 
Single-cell analysis of Salmonella heterogeneity in infected host tissues is a newly emerging field. 206 
Results obtained so far already reveal a previously unanticipated rich infection biology with dozens of 207 
subsets as a result of superimposed distinct molecular stress mechanisms and differential nutrient 208 
access. As we gain deeper insight, we discover more and more heterogeneity and it is likely that 209 
almost every Salmonella might face and specifically responds to a unique host microenvironment. 210 
The data also show a crucial importance of some particular types of host-pathogen encounters for 211 
disease progression and ultimate outcome. On the other hand, we have clearly obtained only the first 212 
glimpses of highly complex scenarios in infected tissues. 213 
 We still largely lack a molecular understanding of the mechanisms that drive the divergent 214 
outcomes of individual encounters. Host microenvironments clearly influence local Salmonella, but in 215 
vitro single-cell studies suggest that intracellular Salmonella itself can also differentially modulate 216 
activities of its host cell [22,23]. In addition to this complex interplay, stochastic variation in 217 
Salmonella and host cells could further complicate the interactions. In the context of antimicrobial 218 
chemotherapy, differential antagonistic host attacks (such as nitric oxide [44,45]) but also inefficient 219 
drug penetration of certain tissue compartments [4] could delay eradication. For all these mechanisms, 220 
we have yet limited in vivo evidence.  221 
 Maybe the most important questions are how we can leverage the increasing knowledge of 222 
key Salmonella subsets for improving infection control. Can we help the host to direct its potent 223 
Salmonella-killing cells more comprehensively to all newly emerging infection foci? Which 224 
properties of resilient Salmonella subsets with high tolerance to antibiotics might exploitable for 225 
specific targeting of these crucial subsets (e.g., [46])? Answering these questions is important since 226 
Salmonella remains a major threat to human health [47]. In fact, this threat might even become more 227 
serious because of rapidly rising antimicrobial resistance and the lack of efficacious vaccines against 228 
major Salmonella serovars. Finally, methods that have been developed primarily using Salmonella as 229 
a model pathogen might be applicable to other major human pathogens, and exciting new approaches 230 
from other infectious diseases such as PET imaging for visualizing infection focus dynamics in live 231 
animals [48] might be informative for salmonellosis.  232 
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 367 
368 
Figure 1: Salmonella heterogeneity in gut-associated tissues in a widely used mouse enteritis model. 369 
Salmonella colonizes the caecum lumen (which is partially equivalent to the human colon) and splits 370 
into two subsets (1). One subset actively proliferates with low virulence gene expression, whereas 371 
the other subset has low growth rate and high expression of virulence genes associated with the SPI-372 
1 type III secretion system (“SPI-1 ON”). The SPI-1 ON subset invades the caecum mucosa and 373 
triggers inflammation that diminishes the density of competing normal gut microbiota, thereby 374 
enabling the SPI-1 OFF Salmonella subset to thrive. Although many invading Salmonella are killed, 375 
some SPI-1 ON Salmonella manage to travel inside dendritic cells from the gut to mesenteric lymph 376 
nodes (mLN). Many Salmonella residing in classical dendritic cells (cDC) do not divide enabling them 377 
to tolerate high doses of antimicrobials, whereas Salmonella in interstitial dendritic cells (iDC) might 378 
proliferate at higher rates and remain sensitive to antibiotics (2). 379 
380 
 381 
Figure 2: Divergent fates and properties of Salmonella subsets in spleen. A) Confocal micrograph of a 382 
spleen cryosection. Salmonella (stained with an anti-lipopolysaccacharide antibody, yellow) reside in 383 
diverse cell types including resident macrophages (MΦ, stained with F4/80, green) and 384 
polymorphonuclear leukocytes (neutrophils; PMN, stained with Ly6G, magenta). Some Salmonella in 385 
macrophages retain internal mCherry fluorescent protein (orange) indicating their viability, whereas 386 
most Salmonella in neutrophils are killed by OCl- (bleach) resulting in compromised Salmonella 387 
envelope and loss of mCherry. B) Divergent growth rates of Salmonella in mouse spleen as indicated 388 
by the TIMER fluorescent protein. TIMER shows different ratios of a rapidly maturing GFP-like 389 
fluorophore (yellow) and a slowly maturing DsRed fluorophore (blue) depending on protein dilution 390 
due to Salmonella cell division. Fluorescence is shown in false color for better visibility for people 391 
with limited red-green discrimination. The inset shows differential access to purine nutrients for 392 
slow (poor access, depends on endogenous biosynthesis) and fast (surplus purine availability, can 393 
use purine as nutrient) Salmonella subsets. C) Heterogeneous Salmonella exposure and responses to 394 
host nitric oxide (NO). The left panel shows a micrograph of an infected spleen section with focal 395 
inflammation. Neturophil-rich abscesses are encircled by inflammatory monocytes expressing high 396 
levels of inducible nitric oxide synthase (iNOS). Salmonella residing in regions with little iNOS 397 
expression experience little NO stress and contain baseline levels of defense proteins HmpA (NO 398 
dioxygenase) and YtfE (repair of NO-damaged iron-sulfur clusters) (1). Salmonella residing in regions 399 
with high NO upregulate specifically these defense proteins and the NO reductase Hcp, but no other 400 
proteins (2). The enhanced NO detoxification capabilities enable this Salmonella subset to diminish 401 
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